Search results
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 7 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 13 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 24 hours agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...
AstraZeneca champions early kidney disease diagnosis with modelling data
Pharmaceutical Technology via Yahoo Finance· 1 day agoAstraZeneca has highlighted both the economic and environmental benefits of implementing early,...
AstraZeneca (LON:AZN) Given New £150 Price Target at Berenberg Bank
ETF DAILY NEWS· 4 days agoAstraZeneca (LON:AZN – Get Free Report) had its target price increased by equities research analysts at Berenberg Bank from £130 ($166.56) to £150 ($192.18) in a research ...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 3 days agoAstrazeneca (AZN) closed the most recent trading day at $80.21, moving +0.24% from the previous...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 3 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
The No-Brainer Buys: 3 Stocks That Are Absolute Must-Owns Right Now
InvestorPlace via Yahoo Finance· 6 days agoToday, we discuss three must-own stocks as major Wall Street indices reach new highs. The rise in...
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 6 days agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...
Centessa Pharma Hires CFO from Fusion After AstraZeneca Takeover
Market Watch· 3 days agoPublished: June 10, 2024 at 7:37 a.m. ETShareResizeBy Dean SealCentessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired ...